Literature DB >> 2395335

Ultrastructural localization of prolactin and chromogranin B messenger ribonucleic acids with biotinylated oligonucleotide probes in cultured pituitary cells.

R V Lloyd1, L Jin, J Song.   

Abstract

A technique for the subcellular localization of prolactin and chromogranin B messenger RNAs (mRNA) in pituitary adenomas by in situ hybridization with biotinylated oligonucleotide probes is described. Ultrastructural examination revealed clusters and individual gold particles in the cytoplasm with this pre-embedding in situ hybridization method. Prolactinomas expressed both prolactin and chromogranin B mRNA, whereas the null cell adenoma expressed only chromogranin B mRNA. Sections of positively labeled cells contained up to 30 gold particles/cell. Treatment of cells with RNAse before hybridization reduced the number of gold particles to less than 1/cell. These results indicate that biotinylated oligonucleotide probes can be used to localize different mRNAs in cultured pituitary cells at the ultrastructural level to study the processing of these molecules within specific cells and for more precise correlation of molecular function with ultrastructural morphology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2395335

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  3 in total

1.  Evaluation of pepsin treatment for electron microscopic RNA in situ hybridization on ultra-thin cryosections of cultured cells.

Authors:  M V Macville; A G Van Dorp; R W Dirks; J A Fransen; A K Raap
Journal:  Histochem Cell Biol       Date:  1996-02       Impact factor: 4.304

Review 2.  In situ hybridization: methods and applications.

Authors:  L Jin; R V Lloyd
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

Review 3.  The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.

Authors:  P Rosa; H H Gerdes
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.